Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Anti-Inhibitor Coagulant Complex (AICC) Lyophilized Powder bulk supplier for pharma manufacturers

Anti-Inhibitor Coagulant Complex (Aicc) Lyophilized Powder Suppliers & Bulk Manufacturers

Available Forms: Lyophilized Powder (Reconstituted for IV infusion)

Available Strengths: 500 units, 1000 units, and 2500 units

Reference Brands: FEIBA(US)

Category: Blood Disorder

Anti-Inhibitor Coagulant Complex (AICC), like FEIBA, provides concentrated clotting factors, bypassing inhibitors in hemophilia. It restores blood clotting, controls bleeding episodes, and reduces bleeding severity. Benefits include rapid bleeding control, improved hemostasis, and saved lives during severe hemorrhages in patients with inhibitors.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Anti-Inhibitor Coagulant Complex (AICC), such as FEIBA, is approved in the US by the FDA and in the EU via EMA for managing bleeding in hemophilia patients with inhibitors. Regulatory approval requires a detailed dossier including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. In the US, the FDA reviews comprehensive clinical and manufacturing information, while the EMA ensures compliance with regional safety and quality requirements. For guidance on dossier preparation, regulatory strategies, and market access, visit PharmaTradz. Ensuring regional compliance is essential for the safe, effective, and timely approval of AICC products worldwide, supporting optimal hemophilia patient care.

Anti-Inhibitor Coagulant Complex (Aicc) Lyophilized Powder — third party manufacturing & bulk supply

Anti-Inhibitor Coagulant Complex (Aicc) Lyophilized Powder is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Anti-Inhibitor Coagulant Complex (Aicc) Lyophilized Powder is supplied as Lyophilized Powder (Reconstituted for IV infusion) — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Anti-Inhibitor Coagulant Complex (Aicc) Lyophilized Powder listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Anti-Inhibitor Coagulant Complex (Aicc)... →
Back to Listing

Frequently Asked Questions

Anti-Inhibitor Coagulant Complex (AICC) Lyophilized Powder is listed as Lyophilized Powder (Reconstituted for IV infusion) in 500 units, 1000 units, and 2500 units. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Anti-Inhibitor Coagulant Complex (AICC) Lyophilized Powder is referenced against FEIBA(US). Reference brands are shown for identification only and remain the property of their respective trademark owners.

Related Products

Prothrombin Complex Concentrate (Pcc) Injection

Strength:
250 IU to 300 IU

Form: Injection

Reference Brands: Kcentra (4-factor PCC), Bebulin VH (3-factor PCC)(US)

View Details
Mesna Injection

Strength:
100 mg/mL

Form: Injection

Reference Brands: Mesnex(US)

View Details
Leucovorin Tablets/Capsule

Strength:
15 mg, 50 mg

Form: Tablet/Capsules

Reference Brands: Folvite(US & EU)

View Details
Pegfilgrastim Injection

Strength:
6 mg per single-use syringe

Form: Injection

Reference Brands: Neulasta, Pelgraz(US), Pegex (Inida)

View Details
Crizanlizumab Infusion

Strength:
10 mg/mL

Form: Infusion Solution

Reference Brands: Adakveo(US)

View Details
Voxelotor Tablets

Strength:
500 mg

Form: Tablet

Reference Brands: Oxbryta(US)

View Details
Deferoxamine Injection

Strength:
500 mg/mL

Form: Injection

Reference Brands: Desferal(US)

View Details
Deferiprone Tablets

Strength:
250 mg, 500 mg

Form: Tablet

Reference Brands: Ferriprox(US)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.